ANI Pharmaceuticals Inc
Closed
SectorHealthcare
82.22 -0.36
Overview
Share price change
24h
Min
82.04
Max
83.9
Income | -61K 27M |
|---|---|
Sales | -9.6M 237M |
P/E Sector Avg | 20.609 50.958 |
EPS | 1.68 |
Profit margin | 11.551 |
Employees | 970 |
EBITDA | -20M 57M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +37.81% upside |
Next Earnings | 7 Aug 2026 |
|---|
Market Cap | -41M 1.8B |
|---|---|
Previous open | 82.58 |
Previous close | 82.22 |
News Sentiment
By Acuity
50%
50%
146 / 342 Healthcare
ANI Pharmaceuticals Inc Chart
Past performance is not a reliable indicator of future results.
About ANI Pharmaceuticals Inc
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.